Crescent Biopharma (CBIO) Equity Ratio (2013 - 2026)
Crescent Biopharma (CBIO) reported Equity Ratio of 0.92 for Q1 2026, up 118.34% year-over-year from 0.42 in Q1 2025, and up 9.28% on a QoQ basis from 0.84 in Q4 2025.
Crescent Biopharma (CBIO) has 14 years of Equity Ratio data on file, last reported at 0.92 in Q1 2026.
- Quarterly Equity Ratio rose 118.34% year-over-year to 0.92 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.92 (up 118.34% YoY) and the FY2025 annual result came in at 0.84, up 294.4% from the prior year.
- Equity Ratio advanced to 0.92 in Q1 2026 per CBIO's latest filing, from 0.84 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.92 in Q1 2026 and bottomed at 5.03 in Q1 2025.
- The 5-year median for Equity Ratio is 0.85 (2024), against an average of 0.38.
- Peak annual rise in Equity Ratio reached 1117.1% in 2025, while the deepest fall reached 695.51% in 2025.
- Tracing CBIO's Equity Ratio over 5 years: stood at 0.83 in 2022, then climbed by 2.31% to 0.85 in 2023, then tumbled by 151.27% to 0.43 in 2024, then surged by 294.4% to 0.84 in 2025, then advanced by 9.28% to 0.92 in 2026.
- Per Business Quant, the three latest CBIO Equity Ratio figures stand at 0.92 (Q1 2026), 0.84 (Q4 2025), and 0.84 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.73 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.77 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.21 |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - | 0.92 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.92 |
| Dec 31, 2025 | 0.84 |
| Sep 30, 2025 | 0.84 |
| Jun 30, 2025 | 0.88 |
| Mar 31, 2025 | -5.03 |
| Dec 31, 2024 | -0.43 |
| Sep 30, 2024 | -0.08 |
| Jun 30, 2024 | 0.82 |
| Mar 31, 2024 | 0.85 |
| Dec 31, 2023 | 0.85 |
| Sep 30, 2023 | 0.87 |
| Jun 30, 2023 | 0.89 |
| Mar 31, 2023 | 0.90 |
| Dec 31, 2022 | 0.83 |
| Sep 30, 2022 | 0.86 |
| Jun 30, 2022 | 0.86 |
| Mar 31, 2022 | 0.84 |
| Dec 31, 2021 | 0.86 |
| Sep 30, 2021 | 0.89 |
| Jun 30, 2021 | 0.90 |
| Mar 31, 2021 | 0.91 |
| Dec 31, 2020 | 0.90 |
| Sep 30, 2020 | 0.92 |
| Jun 30, 2020 | 0.92 |
| Mar 31, 2020 | 0.92 |
| Dec 31, 2019 | 0.92 |
| Sep 30, 2019 | 0.93 |
| Jun 30, 2019 | 0.93 |
| Mar 31, 2019 | 0.94 |
| Dec 31, 2018 | 0.96 |
| Sep 30, 2018 | 0.97 |
| Jun 30, 2018 | 0.97 |
| Mar 31, 2018 | 0.96 |
| Dec 31, 2017 | 0.93 |
| Sep 30, 2017 | 0.94 |
| Jun 30, 2017 | 0.95 |
| Mar 31, 2017 | 0.86 |
| Dec 31, 2016 | 0.83 |
| Sep 30, 2016 | 0.87 |
| Jun 30, 2016 | 0.88 |
| Mar 31, 2016 | 0.85 |
| Dec 31, 2015 | 0.84 |
| Sep 30, 2015 | 0.87 |
| Jun 30, 2015 | 0.89 |
| Mar 31, 2015 | 0.92 |
| Dec 31, 2014 | 0.89 |
| Sep 30, 2014 | 0.92 |
| Jun 30, 2014 | 0.95 |
| Mar 31, 2014 | 0.95 |
| Dec 31, 2013 | 0.55 |